Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05958329 · ClinicalTrials.gov registry record · NA
Short Sessions of HRV Biofeedback
A NA study, sponsored by Icahn School of Medicine at Mount Sinai.
- Completed
- Registry status
- NA
- Development phase
- 127
- Enrollment target
NCT05958329 is a NA study that has completed, run by Icahn School of Medicine at Mount Sinai. The registered enrollment target is 127 participants.
The verdict
NCT05958329, a NA study, has completed, sponsored by Icahn School of Medicine at Mount Sinai.
- COMPLETED
- Registry status
- NA
- Development phase
- 127 participants
- Enrollment target
Study Summary
Remote 5 minute sessions of heart rate variability (HRV) biofeedback will be employed by participants for 5 weeks. Subjects will be followed for a total of 17 weeks. Surveys assessing psychological well being will be completed during the study period. Wearable devices will be worn to monitor HRV response during the study period.
Interventions
- BEHAVIORAL HRV Biofeedback
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 127 participants |
| Start Date | 2021-07-01 |
| Est. Completion | 2022-07-15 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05958329
The ClinicalTrials.gov registry entry for NCT05958329 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 127 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Icahn School of Medicine at Mount Sinai, which has 708 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which HRV Biofeedback is the first listed.
NCT05958329 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05958329 about?
NCT05958329 is a clinical study titled "Short Sessions of HRV Biofeedback". Remote 5 minute sessions of heart rate variability (HRV) biofeedback will be employed by participants for 5 weeks. Subjects will be followed for a total of 17 weeks. Surveys assessing psychological well being will be completed during the study period. Wearable devices will be worn to monitor HRV res...
What is the current status of trial NCT05958329?
This trial is currently completed. It is a NA study. The enrollment target is 127 participants. The study started on 2021-07-01. Estimated completion is 2022-07-15.
What interventions are being tested in trial NCT05958329?
The interventions under investigation include: HRV Biofeedback (BEHAVIORAL).
Who is sponsoring clinical trial NCT05958329?
This trial is sponsored by Icahn School of Medicine at Mount Sinai, which has 708 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.